Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,100 public trials 1,371 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy with Central Lymph Node Compartment Dissection

NCT04339478

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
Locations
  • 1st Propedeutic Department of Surgery, AHEPA University General Hospital, Aristotle University of Thessaloniki Thessaloniki, Greece
  • Department of Surgery, Faculty of Medicine, Hashemite University Zarqa, Jordan
  • Umraniye Education and Research Hospital Istanbul, Turkey (Türkiye)
View Trial Details
Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

NCT04907851

Conditions
Adenocarcinoma, Advanced Solid Tumours, Biliary Tract Diseases, +13 more
Locations
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • The Alfred Hospital - Alfred Health Melbourne, Victoria, Australia
  • Cambridge University Hospital NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Care Glasgow, United Kingdom
View all 13 locations
View Trial Details
Completed

p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246

NCT03268382

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • Medische oncologie, Universitair Ziekenhuis Gent Ghent, Belgium
  • Leuven University Hospitals Leuven, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
  • Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Spain
View Trial Details
Completed

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

NCT02489903

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • Stanford University Palo Alto, California, United States
  • VA Connecticut Cancer Center West Haven, Connecticut, United States
  • Memorial Hospital of South Bend South Bend, Indiana, United States
  • Baptist Health Lexington, Kentucky, United States
View Trial Details
Completed

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

NCT02098343

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

HPV Vaccine Intervention for Young Sexual Minority Men

NCT04032106

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions